keyword
https://read.qxmd.com/read/37692611/microalbuminuria-as-the-tip-of-iceberg-in-type-2-diabetes-mellitus-prevalence-risk-factors-and-associated-diabetic-complications
#21
JOURNAL ARTICLE
Sohaib Asghar, Shoaib Asghar, Tayyab Mahmood, Syed Muhammad Hassan Bukhari, Muhammad Habib Mumtaz, Ali Rasheed
Background Microalbuminuria (MA) is an important clinical marker for the early detection of kidney damage in patients with type 2 diabetes (T2DM). Urine albumin-to-creatinine ratio (ACR), also known as urine microalbumin, is a sign of diabetic nephropathy (DN), which is a prevalent complication of diabetes and can result in end-stage renal disease (ESRD) if not managed. The prevalence of MA in T2DM has been steadily increasing worldwide, making it a significant public health concern. The goal of this study was to estimate the prevalence of MA and its relationship to hypertension and other diabetic complications among people with T2DM...
August 2023: Curēus
https://read.qxmd.com/read/37671124/sex-specific-risks-for-cardiovascular-disease-across-the-glycaemic-spectrum-a-population-based-cohort-study-using-the-uk-biobank
#22
JOURNAL ARTICLE
Christopher T Rentsch, Victoria Garfield, Rohini Mathur, Sophie V Eastwood, Liam Smeeth, Nish Chaturvedi, Krishnan Bhaskaran
BACKGROUND: We sought to examine sex-specific risks for incident cardiovascular disease (CVD) across the full glycaemic spectrum. METHODS: Using data from UK Biobank, we categorised participants' glycated haemoglobin (HbA1c) at baseline as low-normal (<35 mmol/mol), normal (35-41 mmol/mol), pre-diabetes (42-47 mmol/mol), undiagnosed diabetes (≥48 mmol/mol), or diagnosed diabetes. Our outcomes were coronary artery disease (CAD), atrial fibrillation, deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, heart failure, and a composite outcome of any CVD...
September 2023: The Lancet regional health. Europe
https://read.qxmd.com/read/37644964/impact-of-covid-19-lockdown-on-glycemic-weight-blood-pressure-control-and-medication-adherence-in-patients-with-type-2-diabetes
#23
JOURNAL ARTICLE
Ruth Sim, Chun Wie Chong, Navin Kumar Loganadan, Zanariah Hussein, Noor Lita Adam, Shaun Wen Huey Lee
Medication adherence profoundly affects blood glucose management in patients with type 2 diabetes. Measures to contain the COVID-19 pandemic have affected disease management and medication adherence, owing to limited access to healthcare facilities. This study aimed to examine the impact of the COVID-19 lockdown on adherence to glucose-lowering and lipid-lowering therapies (statins), and glycemic, weight, and systolic blood pressure control measures. A retrospective chart review was conducted one year pre- and post- March 18, 2020, for patients receiving glucose-lowering medications and lipid-lowering therapies (statins) in two major public hospitals in Malaysia...
2023: Patient Preference and Adherence
https://read.qxmd.com/read/37598214/evaluation-of-the-diabetes-care-cascade-and-compliance-with-who-global-coverage-targets-in-iran-based-on-steps-survey-2021
#24
JOURNAL ARTICLE
Sina Azadnajafabad, Naser Ahmadi, Negar Rezaei, Mohammad-Mahdi Rashidi, Sahar Saeedi Moghaddam, Esmaeil Mohammadi, Mohsen Abbasi-Kangevari, Mohammadreza Naderian, Erfan Ghasemi, Yosef Farzi, Ameneh Kazemi, Arezou Dilmaghani-Marand, Moein Yoosefi, Shahabeddin Rezaei, Maryam Nasserinejad, Nima Fattahi, Nazila Rezaei, Rosa Haghshenas, Elmira Foroutan Mehr, Sogol Koolaji, Farideh Razi, Shirin Djalalinia, Bagher Larijani, Farshad Farzadfar
This study aimed to investigate the diabetes mellitus (DM) and prediabetes epidemiology, care cascade, and compliance with global coverage targets. We recruited the results of the nationally representative Iran STEPS Survey 2021. Diabetes and prediabetes were two main outcomes. Diabetes awareness, treatment coverage, and glycemic control were calculated for all population with diabetes to investigate the care cascade. Four global coverage targets for diabetes developed by the World Health Organization were adopted to assess the DM diagnosis and control status...
August 19, 2023: Scientific Reports
https://read.qxmd.com/read/37581619/atorvastatin-lowers-68-ga-dotatate-uptake-in-coronary-arteries-bone-marrow-and-spleen-in-individuals-with-type-2-diabetes
#25
JOURNAL ARTICLE
Reindert F Oostveen, Yannick Kaiser, Mia R Ståhle, Nick S Nurmohamed, Evangelos Tzolos, Marc R Dweck, Jeffrey Kroon, Andrew J Murphy, Damini Dey, Piotr J Slomka, Hein J Verberne, Erik S G Stroes, Nordin M J Hanssen
AIMS/HYPOTHESIS: Inflammation is a core component of residual cardiovascular risk in type 2 diabetes. With new anti-inflammatory therapeutics entering the field, accurate markers to evaluate their effectiveness in reducing cardiovascular disease are paramount. Gallium-68-labelled DOTATATE (68 Ga-DOTATATE) has recently been proposed as a more specific marker of arterial wall inflammation than 18 F-fluorodeoxyglucose (18 F-FDG). This study set out to investigate whether 68 Ga-DOTATATE uptake is amenable to therapeutic intervention in individuals with type 2 diabetes...
August 15, 2023: Diabetologia
https://read.qxmd.com/read/37528178/risk-of-first-time-major-cardiovascular-event-among-individuals-with-newly-diagnosed-type-2-diabetes-data-from-danish-registers
#26
JOURNAL ARTICLE
Alexander C Falkentoft, Thomas Alexander Gerds, Bochra Zareini, Filip K Knop, Lars Køber, Christian Torp-Pedersen, Morten Schou, Niels E Bruun, Anne-Christine Ruwald
AIMS/HYPOTHESIS: We aimed to examine whether individuals with initial omission of glucose-lowering drug treatment (GLDT), including those achieving initial remission of type 2 diabetes, may experience a higher risk of major adverse cardiovascular events (MACE) compared with well-controlled individuals on GLDT after a new type 2 diabetes diagnosis in real-world clinical practice. Furthermore, we examined whether a higher risk could be related to lower initiation of statins and renin-angiotensin system inhibitors (RASi)...
August 2, 2023: Diabetologia
https://read.qxmd.com/read/37520674/metformin-use-among-obese-patients-with-prediabetes-in-qassim-saudi-arabia-an-observational-study
#27
JOURNAL ARTICLE
Osamah M Alfayez, Sumaia N Alfuraih, Basmah I Alsalamah, Hadeel M Almendeel, Omar S Alkhezi, Saad Alharbi, Naief A Alwohaibi, Muhammad Kamran Rasheed
BACKGROUND AND AIMS: The high prevalence of prediabetes and diabetes mellitus and its secondary complications in Saudi Arabia is a major healthcare concern. Evidence suggests that despite evidence-based efficacy and safety, metformin is underutilized in prediabetic obese patients. Thus, the aim of this study was to investigate the use of metformin in prediabetic obese patients in the Qassim region of Saudi Arabia. METHODS: Prediabetic patients' electronic health records were accessed and screened from 2017 to 2021...
September 2023: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://read.qxmd.com/read/37519117/limb-and-cardiovascular-event-risk-in-type-1-and-2-diabetic-patients-with-peripheral-artery-disease
#28
JOURNAL ARTICLE
Daniel Sykora, Christine Firth, Marlene Girardo, Andrew Tseng, Paul Wennberg, David Liedl, Fadi Shamoun
<b/> Background: Peripheral artery disease (PAD) is a risk factor for adverse limb events (LE) and cardiovascular events (CVE) that coexists with type 1 (T1) and 2 (T2) diabetes mellitus (DM). Little is known about comparative risk of LE and CVE in T1/T2 DM patients with PAD. Patients and methods: We queried our database of 40,144 patients ≥18 years old who underwent ankle brachial index (ABI) measurement from 01/1996-02/2020. We isolated T1/T2 DM patients with PAD diagnosed by ankle brachial index (ABI; low [<1...
September 2023: VASA. Zeitschrift Für Gefässkrankheiten
https://read.qxmd.com/read/37478203/ceramides-as-risk-markers-for-future-cardiovascular-events-and-all-cause-mortality-in-long-standing-type-1-diabetes
#29
JOURNAL ARTICLE
Asger Wretlind, Viktor R Curovic, Tommi Suvitaival, Simone Theilade, Nete Tofte, Signe A Winther, Tina Vilsbøll, Henrik Vestergaard, Peter Rossing, Cristina Legido-Quigley
Ceramides are lipid molecules involved in inflammation-related signaling. Recent studies have shown that higher amounts of specific circulating ceramides and their ratios are associated with future development of cardiovascular (CV) disease (CVD). We examined the associations between serum ceramide levels with CVD, kidney failure, and all-cause mortality in individuals with longstanding type 1 diabetes (T1D). We included 662 participants with T1D and 6-year follow-up, with a mean age of 55 years and mean diabetes duration of 33 years...
July 21, 2023: Diabetes
https://read.qxmd.com/read/37473636/comparison-of-coronary-artery-calcium-score-and-cardiovascular-risk-stratification-by-european-society-of-cardiology-guidelines-and-steno-type-1-risk-engine-in-statin-na%C3%A3-ve-adults-with-type-1-diabetes
#30
JOURNAL ARTICLE
Yuhan A Goh, Nick S R Lan, Kathryn Linn, Chris Wood, Ashu Gupta, Bu B Yeap, P Gerry Fegan
BACKGROUND: Coronary artery calcium (CAC) is a marker of atherosclerotic cardiovascular disease (CVD). However, for patients with type 1 diabetes (T1D), its relationship with T1D-specific cardiovascular (CV) risk-stratification tools is unknown. AIMS: Assess prevalence of CAC and evaluate relationship between CAC and T1D-specific CV risk-stratification methods in T1D. METHODS: Cross-sectional study of adults with T1D age 20-60 years, statin-naïve and no history of CVD...
August 2023: Journal of Diabetes and its Complications
https://read.qxmd.com/read/37415152/both-ldl-and-hdl-particle-concentrations-associate-positively-with-an-increased-risk-of-developing-microvascular-complications-in-patients-with-type-2-diabetes-lost-protection-by-hdl-zodiac-63
#31
JOURNAL ARTICLE
Arno R Bourgonje, Margery A Connelly, Harry van Goor, Peter R van Dijk, Robin P F Dullaart
BACKGROUND: Triglyceride-rich lipoproteins (TRL) and low-density lipoproteins (LDL) are associated positively whereas high-density lipoproteins (HDL) are associated inversely with the development of new-onset type 2 diabetes (T2D). Here we studied potential associations between these lipoprotein particle concentrations and the risk of developing microvascular complications in patients with established T2D. METHODS: Lipoprotein particle concentrations (TRLP, LDLP, and HDLP) were determined in 278 patients with T2D participating in a primary care-based longitudinal cohort study (Zwolle Outpatient Diabetes project Integrating Available Care [ZODIAC] study) leveraging the Vantera nuclear magnetic resonance (NMR) platform using the LP4 algorithm...
July 6, 2023: Cardiovascular Diabetology
https://read.qxmd.com/read/37396431/10-years-of-syntax-closing-an-era-of-clinical-research-after-identifying-new-outcome-determinants
#32
REVIEW
Patrick W Serruys, Pruthvi C Revaiah, Kai Ninomiya, Shinichiro Masuda, Nozomi Kotoku, Shigetaka Kageyama, Yoshinobu Onuma, Marie Angele Morel, Scot Garg, Ted Feldman, Arie Pieter Kappetein, David R Holmes, Michael J Mack, Friedrich-Wilhelm Mohr
The SYNTAX trial randomized patients equally eligible for coronary artery bypass grafting or percutaneous coronary intervention using the Heart Team approach. The SYNTAXES study achieved a follow-up rate of 93.8% and reported the 10-year vital status. Factors associated with increased mortality at 10 years were pharmacologically treated diabetes mellitus, increased waist circumference, reduced left ventricular function, prior cerebrovascular and peripheral vascular disease, western Europe and North American descent, current smoking, chronic obstructive pulmonary disease, elevated C-reactive protein, anemia, and an increase in HbA1c...
June 2023: JACC Asia
https://read.qxmd.com/read/37301375/association-of-metformin-dipeptidyl-dipeptidase-4-inhibitors-and-insulin-with-covid-19-related-hospital-outcomes-in-patients-with-type-2-diabetes
#33
JOURNAL ARTICLE
Derrick Obiri-Yeboah, James Bena, Mahmoud Alwakeel, Lauren Buehler, Vinni Makin, Keren Zhou, Kevin M Pantalone, M Cecilia Lansang
OBJECTIVE: The effects of diabetes medications on COVID-19 hospitalization outcomes have not been consistent. We sought to determine the effect of metformin, DPP-4 inhibitors (DPP-4i), and insulin on admission to the intensive care unit (ICU), need for assisted ventilation, development of renal insufficiency, and mortality, in patients admitted with COVID-19 infection after controlling for clinical variables and other relevant diabetes-related medications in patients with type 2 DM. METHODS: This was a retrospective study of patients hospitalized with COVID-19 from a single hospital system...
June 8, 2023: Endocrine Practice
https://read.qxmd.com/read/37223892/inequalities-in-the-management-of-diabetic-kidney-disease-in-uk-primary-care-a-cross-sectional-analysis-of-a-large-primary-care-database
#34
JOURNAL ARTICLE
Katherine Phillips, Jonathan M Hazlehurst, Christelle Sheppard, Srikanth Bellary, Wasim Hanif, Muhammad Ali Karamat, Francesca L Crowe, Anna Stone, G Neil Thomas, Javeria Peracha, Anthony Fenton, Christopher Sainsbury, Krishnarajah Nirantharakumar, Indranil Dasgupta
OBJECTIVE: To determine differences in the management of Diabetic Kidney Disease (DKD) relevant to patient sex, ethnicity and socioeconomic group in UK primary care. RESEARCH DESIGN AND METHODS: A cross-sectional analysis as of 1st January 2019 was undertaken using IQVIA Medical Research Data (IMRD) dataset, to determine the proportion of people with DKD managed in accordance with national guidelines, stratified by demographics. Robust Poisson regression models were used to calculate adjusted risk ratios (aRR) adjusting for age, sex, ethnicity, and social deprivation...
May 24, 2023: Diabetic Medicine: a Journal of the British Diabetic Association
https://read.qxmd.com/read/37206443/risk-of-diabetic-retinopathy-and-retinal-neurodegeneration-in-individuals-with-type-2-diabetes-beichen-eye-study
#35
JOURNAL ARTICLE
Zhengwei Yang, Qingyan Liu, Dejia Wen, Zihao Yu, Chuanzhen Zheng, Fei Gao, Chen Chen, Liying Hu, Yu Shi, Xiuqing Zhu, Juping Liu, Yan Shao, Xiaorong Li
OBJECTIVE: Our aim was to evaluate associations of different risk factors with odds of diabetic retinopathy (DR) diagnosis and retinal neurodegeneration represented by macular ganglion cell-inner plexiform layer (mGCIPL). METHODS: This cross-sectional study analyzed data from individuals aged over 50 years examined between June 2020 and February 2022 in the community-based Beichen Eye Study on ocular diseases. Baseline characteristics included demographic data, cardiometabolic risk factors, laboratory findings, and medications at enrollment...
2023: Frontiers in Endocrinology
https://read.qxmd.com/read/37160786/glucagon-like-peptide-1-analog-therapy-in-rare-genetic-diseases-monogenic-obesity-monogenic-diabetes-and-spinal-muscular-atrophy
#36
JOURNAL ARTICLE
Hussein Zaitoon, Ronit Lubetzky, Achiya Z Amir, Hadar Moran-Lev, Liora Sagi, Michal Yacobi-Bach, Ophir Borger, Efrat Chorna, Yael Lebenthal, Avivit Brener
AIM: Implementing genetic analyses have unraveled rare alterations causing early-onset obesity and complications, in whom treatment is challenging. We aimed to report on the effects of adjuvant off-label therapy with liraglutide, glucagon-like peptide-1 analogue (GLP-1a), in rare genetic diagnoses. METHODS: Case scenarios and review of the literature. RESULTS: Case 1: Nine-year-old boy with early-onset severe obesity and nonalcoholic fatty liver disease (NAFLD) due to a homozygous mutation in the MC4R gene deteriorated under lifestyle change and metformin therapy [at 10...
May 9, 2023: Acta Diabetologica
https://read.qxmd.com/read/37133433/bacterial-quantity-and-interleukin-17-expression-in-necrotic-teeth-with-apical-periodontitis-from-type-ii-diabetic-patients
#37
JOURNAL ARTICLE
Alaa Aldoss, Maha Alghofaily, Fahd Alsalleeh
UNLABELLED: Diabetes mellitus (DM) increases the susceptibility to infection. A plausible association between apical periodontitis (AP) and DM has been reported, but the underlying mechanism is not yet elucidated. AIM: To investigate the bacterial quantity and the expression of interleukin-17 (IL-17) in necrotic teeth with AP in type 2 diabetes mellitus (T2DM), pre-diabetic, and non-diabetic control patients. METHODOLOGY: Sixty-five patients with necrotic pulp and AP (periapical index (PAI) scores ≥3) were included...
May 3, 2023: International Endodontic Journal
https://read.qxmd.com/read/37088651/advanced-lipoprotein-profile-identifies-atherosclerosis-better-than-conventional-lipids-in-type-1-diabetes-at-high-cardiovascular-risk
#38
JOURNAL ARTICLE
Tonet Serés-Noriega, Emilio Ortega, Marga Giménez, Verónica Perea, Laura Boswell, Karla Mariaca, Carla Font, Alex Mesa, Clara Viñals, Jesús Blanco, Irene Vinagre, Adriana Pané, Enric Esmatjes, Ignacio Conget, Antonio J Amor
BACKGROUND AND AIMS: People with type 1 diabetes (T1D) present lipoprotein disturbances that could contribute to their increased cardiovascular disease (CVD) risk. We evaluated the relationship between lipoprotein alterations and atherosclerosis in patients with T1D. METHODS AND RESULTS: Cross-sectional study in subjects with T1D, without previous CVD, but high-risk (≥40 years, nephropathy, or ≥10 years of evolution of diabetes with another risk factor)...
April 5, 2023: Nutrition, Metabolism, and Cardiovascular Diseases: NMCD
https://read.qxmd.com/read/37083665/association-of-health-related-social-needs-with-quality-and-utilization-outcomes-in-a-medicare-advantage-population-with-diabetes
#39
JOURNAL ARTICLE
Jessica L Ryan, Stephanie M Franklin, Melanie Canterberry, Charron L Long, Andy Bowe, Brandy D Roy, Danielle Hessler, Benjamin Aceves, Laura M Gottlieb
IMPORTANCE: Recent research highlights the association of social determinants of health with health outcomes of patients with type 2 diabetes (T2D). OBJECTIVE: To examine associations between health-related social needs (HRSNs) and health care quality and utilization outcomes in a Medicare Advantage population with T2D. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used medical and pharmacy claims data from 2019. An HRSN survey was given between October 16, 2019, and February 29, 2020, to Medicare Advantage beneficiaries...
April 3, 2023: JAMA Network Open
https://read.qxmd.com/read/37059389/cardiovascular-risk-factors-and-adherence-to-cardiovascular-protection-practice-guidelines-in-adults-with-type-1-diabetes-a-better-registry-cross-sectional-analysis
#40
JOURNAL ARTICLE
Houssein Madar, Marie-Laure Lalanne-Mistrih, Maha Lebbar, Zekai Wu, Yves Robitaille, Jacques Pelletier, Caroline Grou, Anne-Sophie Brazeau, Rémi Rabasa-Lhoret
OBJECTIVES: Cardiovascular disease (CVD) is major cause of morbidity and mortality in people with type 1 diabetes (PWT1D). We assessed CV risk factors and pharmacological treatment in a large Canadian cohort of PWT1D. METHODS: This cross-sectional study used data from adult PWT1D in the BETTER Registry (n=974). CVD risk factors status, diabetes complications and treatments (used as proxy for blood pressure and dyslipidemia) were self-reported through online questionnaires...
April 12, 2023: Canadian Journal of Diabetes
keyword
keyword
47350
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.